4-苯基丁酸钠通过减轻内质网应激保护急性呼吸窘迫综合征相关右心室功能障碍大鼠
该研究将60只雄性SD大鼠随机分为对照组、脂多糖模型组、4-苯基丁酸钠预防组和治疗组,每组15只。模型组经气管切开后气管内滴注脂多糖10 mg/kg建立急性呼吸窘迫综合征模型;预防组和治疗组分别在脂多糖前2小时和后2小时灌胃4-苯基丁酸钠500 mg/kg。处理后12小时超声评估右心室功能,并检测血清和心肌炎症因子及心肌内质网应激标志蛋白。结果显示,4-苯基丁酸钠预防组和治疗组三尖瓣环收缩期位移较模型组显著增加,右心室舒张末期内径显著减小,炎症因子和内质网应激标志蛋白表达显著降低,预防组与治疗组各指标无显著差异。作者认为内质网应激参与急性呼吸窘迫综合征相关右心室功能障碍,4-苯基丁酸钠可通过抑制内质网应激和减轻炎症保护右心室功能。
要点
- 在脂多糖10 mg/kg气管内滴注诱导的急性呼吸窘迫综合征大鼠中,4-苯基丁酸钠500 mg/kg灌胃(脂多糖前2小时或后2小时)可改善右心室功能。
- 4-苯基丁酸钠预防组和治疗组三尖瓣环收缩期位移分别为3.08±0.65 mm和2.96±0.61 mm,均高于模型组的2.48±0.45 mm。
- 4-苯基丁酸钠预防组和治疗组右心室舒张末期内径分别为3.67±0.58 mm和3.60±0.61 mm,均低于模型组的4.18±0.71 mm。
- 4-苯基丁酸钠可降低血清和心肌肿瘤坏死因子-α、白细胞介素-1β、白细胞介素-6水平,并降低心肌GRP78、CHOP、caspase-12、caspase-3表达(均P<0.05)。
- 4-苯基丁酸钠预防组与治疗组各指标无显著差异(均P>0.05),提示预防与治疗给药效果相似。
适用人群与场景
- 雄性Sprague-Dawley大鼠,经气管切开后气管内滴注脂多糖10 mg/kg建立急性呼吸窘迫综合征模型。
- 对照组给予等量生理盐水。
处置流程与药物剂量
- 4-苯基丁酸钠预防组于脂多糖造模前2小时灌胃4-苯基丁酸钠500 mg/kg。
- 4-苯基丁酸钠治疗组于脂多糖造模后2小时灌胃4-苯基丁酸钠500 mg/kg。
- 处理后12小时行超声心动图评估右心室功能,随后放血处死大鼠,采集血清和右心室组织。
研究设计与关键结果
- 研究类型:动物实验;60只雄性Sprague-Dawley大鼠随机分为对照组、脂多糖模型组、4-苯基丁酸钠预防组和治疗组,每组15只。
- 与对照组比较,脂多糖模型组肺动脉最大压力阶差、肺动脉加速时间、三尖瓣环收缩期位移显著降低,右心室舒张末期内径显著增加,血清和心肌肿瘤坏死因子-α、白细胞介素-1β、白细胞介素-6水平及心肌GRP78、CHOP、caspase-12、caspase-3表达显著升高。
- 与脂多糖模型组比较,4-苯基丁酸钠预防组和治疗组三尖瓣环收缩期位移显著增加(mm:3.08±0.65、2.96±0.61 vs. 2.48±0.45),右心室舒张末期内径显著减小(mm:3.67±0.58、3.60±0.61 vs. 4.18±0.71)。
- 与脂多糖模型组比较,4-苯基丁酸钠预防组和治疗组血清肿瘤坏死因子-α(ng/L)分别为187.98±18.98、176.08±17.98 vs. 332.00±19.90,心肌肿瘤坏死因子-α(ng/L)分别为135.06±19.00、132.78±17.00 vs. 155.00±20.00;血清白细胞介素-1β(ng/L)分别为12.07±2.98、11.05±2.41 vs. 24.06±4.01,心肌白细胞介素-1β(ng/L)分别为19.89±2.80、21.06±2.80 vs. 26.00±2.60;血清白细胞介素-6(ng/L)分别为42.98±7.90、34.05±6.09 vs. 89.80±10.07,心肌白细胞介素-6(ng/L)分别为129.45±25.00、127.08±26.06 vs. 145.77±23.00,均显著降低。
- 与脂多糖模型组比较,4-苯基丁酸钠预防组和治疗组心肌GRP78/GAPDH分别为0.090±0.070、0.103±0.060 vs. 0.167±0.090,CHOP/GAPDH分别为0.109±0.090、0.090±0.080 vs. 0.186±0.090,caspase-12/GAPDH分别为0.769±0.230、0.799±0.210 vs. 1.040±0.350,caspase-3/GAPDH分别为0.391±0.060、0.401±0.054 vs. 0.603±0.340,均显著降低(均P<0.05)。
- 4-苯基丁酸钠预防组与治疗组各指标比较均无显著差异(均P>0.05)。
证据类型、等级与局限
- 证据类型:动物实验(大鼠模型)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 该大鼠实验提示内质网应激参与急性呼吸窘迫综合征相关右心室功能障碍,4-苯基丁酸钠可通过抑制内质网应激和减轻炎症保护右心室功能,预防与治疗给药效果相似;原文未据此给出临床推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the role of endoplasmic reticulum stress (ERS) in rats with acute respiratory distress syndrome (ARDS) related right ventricular dysfunction and the protective effect of sodium 4-phenylbutyrate (4-PBA) on right ventricle.
METHODS: Sixty male Spragne-Dawley (SD) rats were randomly divided into control group (CON group), lipopolysaccharide (LPS) model group, 4-PBA prevention group and 4-PBA treatment group, with 15 rats in each group. ARDS rat model was established by intratracheal instillation of LPS 10 mg/kg after tracheotomy; CON group was given the same amount of saline. 4-PBA prevention group and 4-PBA treatment group were given 4-PBA 500 mg/kg intragastric administration 2 hours before and after LPS respectively. Echocardiography was performed 12 hours after treatment to evaluate the right ventricular function. Then, the rats were sacrificed by bloodletting, and the serum and right ventricular tissue were harvested. The histopathological changes of myocardial were observed by hematoxylin-eosin (HE) staining, the levels of tumor necrosis factor-α (TNF-α), interleukins (IL-1β and IL-6) in serum and myocardial were detected by enzyme linked immunosorbent assay (ELISA), and Western Blot was used to detect the expression of the marker proteins of ERS in myocardial, including glucose regulatory protein 78 (GRP78), C/EBP cyclic adenosine phosphate reaction primitive binding transcription factor homologous protein (CHOP), caspase-12 and caspase-3.
RESULTS: Compared with the CON group, the echocardiography showed pulmonary artery maximum pressure gradient (PAmaxPG), pulmonary artery acceleration time (PAAT), tricuspid annular plane systolic excursion (TAPSE) in LPS model group were significantly decreased, and right ventricular end-diastolic excursion (RVDd) was significantly increased, and the levels of TNF-α, IL-1β and IL-6 in serum and myocardial, as well as the expressions of GRP78, CHOP, caspase-12 and caspase-3 in myocardial were significantly increased. Compared with LPS model group, TAPSE of 4-PBA preventive and treatment groups were significantly increased (mm: 3.08±0.65, 2.96±0.61 vs. 2.48±0.45), RVDd were significantly decreased (mm: 3.67±0.58, 3.60±0.61 vs. 4.18±0.71), the levels of TNF-α, IL-1β and IL-6 in serum and myocardial were significantly decreased [TNF-α (ng/L): 187.98±18.98, 176.08±17.98 vs. 332.00±19.90 in serum, 135.06±19.00, 132.78±17.00 vs. 155.00±20.00 in myocardial; IL-1β(ng/L): 12.07±2.98, 11.05±2.41 vs. 24.06±4.01 in serum, 19.89±2.80, 21.06±2.80 vs. 26.00±2.60 in myocardial; IL-6 (ng/L): 42.98±7.90, 34.05±6.09 vs. 89.80±10.07 in serum, 129.45±25.00, 127.08±26.06 vs. 145.77±23.00 in myocardial]; the expressions of GRP78, CHOP, caspase-12 and caspase-3 in myocardial were significantly decreased (GRP78/GAPDH: 0.090±0.070, 0.103±0.060 vs. 0.167±0.090, CHOP/GAPDH: 0.109±0.090, 0.090±0.080 vs. 0.186±0.090, caspase-12/GAPDH: 0.769±0.230, 0.799±0.210 vs. 1.040±0.350, caspase-3/GAPDH: 0.391±0.060, 0.401±0.054 vs. 0.603±0.340), with statistically significant differences (all P < 0.05). There were no significant differences in each indexes between 4-PBA prevention group and 4-PBA treatment group (all P > 0.05).
CONCLUSIONS: ERS is involved in ARDS-related right ventricular dysfunction. 4-PBA can protect the right ventricular function of ARDS rats by inhibiting ERS and alleviating inflammation, and the preventive and therapeutic effects of 4-PBA are similar.
参考来源
- Ma S, Zuo X, Wang Y, et al. [Protective effect of sodium 4-phenylbutyrate on rats with acute respiratory distress syndrome related right ventricular dysfunction by alleviating endoplasmic reticulum stress]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019. PMID: 31771727. doi:10.3760/cma.j.issn.2095-4352.2019.10.017
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。